Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Using cystic fibrosis patient-derived induced pluripotent stem cells to study the effects of cystic fibrosis transmembrane conductance regulator mutations on islet development

EF 2022-23

Résumé
Cystic fibrosis (CF) is a genetic disease caused by the inheritance of mutations and affects many organ systems including the lung and pancreas. While the life expectancy for CF has increased over the years, there has been an associated increase in the emergence of secondary complications as patients are living longer. A prevalent complication is the development of a unique form of diabetes called cystic fibrosis-related diabetes (CFRD). CFRD is mainly characterized by abnormal glucose regulation, insulin insufficiency, and the loss of islets, a specific group of pancreatic cells that normally produce hormones like insulin that regulate blood glucose. The onset of CFRD is not fully understood, but recent work in the field has begun to reveal that CF patients, and those that eventually develop CFRD, exhibit abnormalities in their islets and glucose levels early on in life. Therefore, we hypothesize that early on in development, the mutations responsible for CF may be inhibiting normal islet development, predisposing CF patients to develop CFRD later in life. To investigate if this is true, we will mimic early developmental processes using stem cells derived from CF patients. Specifically, the formation of the pancreatic islets will be investigated. This will allow us to analyze how normal islet development and function are impacted by CF mutations at different points during the developmental process. Current gaps in understanding CFRD will be addressed, and possible therapeutic targets may be identified. Further, this will set the foundations for a platform that may study if CFRD prevention is possible.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
486590
Name
Cho Alex
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Using cystic fibrosis patient-derived induced pluripotent stem cells to study the effects of cystic fibrosis transmembrane conductance regulator mutations on islet development
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Beta-Like Cells; Cystic Fibrosis (Cf); Cystic Fibrosis Related Diabetes (Cfrd); Induced Pluripotent Stem Cells (Ipscs); Islet Development; Pancreas; Stem Cell Differentiation
Abstract
Cystic fibrosis (CF) is a genetic disease caused by the inheritance of mutations and affects many organ systems including the lung and pancreas. While the life expectancy for CF has increased over the years, there has been an associated increase in the emergence of secondary complications as patients are living longer. A prevalent complication is the development of a unique form of diabetes called cystic fibrosis-related diabetes (CFRD). CFRD is mainly characterized by abnormal glucose regulation, insulin insufficiency, and the loss of islets, a specific group of pancreatic cells that normally produce hormones like insulin that regulate blood glucose. The onset of CFRD is not fully understood, but recent work in the field has begun to reveal that CF patients, and those that eventually develop CFRD, exhibit abnormalities in their islets and glucose levels early on in life. Therefore, we hypothesize that early on in development, the mutations responsible for CF may be inhibiting normal islet development, predisposing CF patients to develop CFRD later in life. To investigate if this is true, we will mimic early developmental processes using stem cells derived from CF patients. Specifically, the formation of the pancreatic islets will be investigated. This will allow us to analyze how normal islet development and function are impacted by CF mutations at different points during the developmental process. Current gaps in understanding CFRD will be addressed, and possible therapeutic targets may be identified. Further, this will set the foundations for a platform that may study if CFRD prevention is possible.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Cho, Alex
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~